Ferric derisomaltose for heart failure

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 2 trial. Mid-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 12 Jun 2026: Trial registered, NCT07643818
  2. 19 Jun 2026: Trial started, NCT07643818

The trials

NCT07643818: Intravenous Iron to Improve Symptoms, Quality of Life and Exercise Capacity in HFpEF With Iron Deficiency

State
Under way
Phase
Phase 2
People
150 planned
Started
19 Jun 2026
Primary completion
Jul 2029
Arms
Intravenous Iron
Results
None posted
  1. 12 Jun 2026: Trial registered
  2. 19 Jun 2026: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 2 trial

About the treatment

Kind of treatment: Drug.

Also known as Monoferric.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.